The spring-driven pre-filled pen

YpsoFlow is a spring-driven, pre-filled pen platform for GLP-1 and peptide therapies, which delivers doses of up to 0.80mL with a low-force mechanism and audible dose feedback. The pen supports sustainability goalsthrough the use of two bio-based plastics. It also comes with Ypsomed’s platform services, which include human factors and interchangeability studies.

• For GLP-1 and other peptide therapies, YpsoFlow supports doses of up to 0.80 mL.
• Spring-driven mechanism with low injection force, non-protruding dose button, and audible dose feedback.
• Self-administration with user steps according to established injection device standards.
• Supports eco-design principles and simplified material handling with the help of two bio-based plastics.
• An original design manufacturer (ODM) platform that supports interchangeability and regulatory integration.